Plerixafor Solution
Product Images NDC 55150-356

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Plerixafor (NDC 55150-356). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Plerixafor-fig1 (Plerixafor Fig1)

Label for Plerixafor Injection 24 mg per 1.2 mL (20 mg/mL) solution for subcutaneous injection. The product is a human prescription drug manufactured in India for Eugia US LLC, located in E. Windsor, NJ. The label includes NDC 55150-356-01, a barcode, and a QR code.*

FDA Label Image

Package Label-principal Display Panel (24 mg per 1.2 mL (20 mg/mL) Container-Carton Label)

Plerixafor Injection 24 mg per 1.2 mL (20 mg/mL) solution for subcutaneous injection, distributed by Eugia US LLC. The label includes dosage form, concentration, storage instructions, and states single-dose vial with no preservatives. The product is made in India and includes a barcode and lot information.*

FDA Label Image

Structural Formula (Plerixafor Str)

Chemical structure of plerixafor, showing two macrocyclic nitrogen-containing rings connected by a benzene ring and a methylene bridge.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.